Company Statement: Takeda to acquire Nycomed - transaction will transform Takeda’s global business
MLex Summary: Takeda Pharmaceuticals and Nycomed jointly announced today that Takeda will acquire Nycomed for 9.6 billion euros from a consortium of private equity funds led by Nordic Capital Funds, including,...To view the full article, register now.
Already a subscriber? Click here to view full article